Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899617 | 1.00 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| Uridine SCHEMBL7700216 | 0.89 | SLC29A1 (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL3970946 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL16555404 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL5033515 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL6663083 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL2424283 | 0.88 | LMNA (0.64) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL62505 | 0.88 | CYP2C19 (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL11481461 | 0.88 | LMNA (0.61) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL14931005 | 0.88 | CYP2C19 (0.62) | LMNANT5EHIF1AADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3359670-B2 | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS | MODERNATX INC (US) | 2024-02-14 | — | — | EP | claimed |
| EP-3359670-B1 | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS | MODERNATX INC (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2002062924-A1 | INSTANT DEGRADATION OF PLASTICS TO SOLUBLE NON-TOXIC PRODUCTS | ROSEN OREN (IL) | 2002-08-15 | — | — | WO | claimed |
| US-20020004590-A1 | Method for producing nucleoside-5'-phosphate ester | MIHARA YASUHIRO (JP) | 2002-01-10 | — | — | US | claimed |
| US-5420105-A | Drug delivery to targeted cells | ALETHEON PHARMACEUTICALS, INC. | 1995-05-30 | — | — | US | claimed |
| WO-2024133160-A1 | HEPATITIS B COMPOSITIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-06-27 | — | — | WO | disclosed |
| EP-4387596-A1 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | GlaxoSmithKline Biologicals SA (BE) | 2024-06-26 | — | — | EP | disclosed |
| EP-4387597-A1 | FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF | GlaxoSmithKline Biologicals SA (BE) | 2024-06-26 | — | — | EP | disclosed |
| CN-114206463-B | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-11993777-B2 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | AKOUOS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| CN-118043306-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2024097875-A1 | FUSION PROTEINS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS | SHATTUCK LABS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-6355472-B2 | ACID PHOSPHATASE | AJINOMOTO CO., INC. (JP) | 2002-03-12 | — | — | US | disclosed |
| US-20020004590-A1 | Method for producing nucleoside-5'-phosphate ester | MIHARA YASUHIRO (JP) | 2002-01-10 | — | — | US | disclosed |
| EP-1170370-A2 | Method for producing nucleotide by fermentation | Ajinomoto Co., Inc. (JP) | 2002-01-09 | — | — | EP | disclosed |
| US-6207435-B1 | MUTANT ACID PHOSPHATASE HAVING DECREASED MICHAELIS CONSTANT FOR A NUCLEOSIDE AND/OR INCREASED TEMPERATURE STABILITY; FOR EFFICIENT PHOSPHORYLATION OF NUCLEOSIDES TO PRODUCE NUCLEOTIDES | AJINOMOTO CO., INC. (JP) | 2001-03-27 | — | — | US | disclosed |
| US-6015697-A | ECONOMICAL AND EFFICIENT PROCESS BY REACTING A NUCLEOSIDE WITH A PHOSPHATE DONOR GROUP IN PRESENCE OF MUTANT ACID PHOSPHATASE WITH DECREASED MICHAELIS CONSTANT FOR NUCLEOSIDE OR INCREASED TEMPERATURE STABILITY | AJINOMOTO CO., INC. (JP) | 2000-01-18 | — | — | US | disclosed |
| US-6010851-A | ALLOWING AN ACID PHOSPHATASE HAVING A LOWERED PHOSPHOMONOESTERASE ACTIVITY TO ACT UNDER A CONDITION OF PH 3.0 TO 5.5 ON A NUCLEOSIDE AND A PHOSPHATE GROUP DONOR | AJINOMOTO CO., INC. (JP) | 2000-01-04 | — | — | US | disclosed |
| EP-0857788-A2 | Method for producing nucleoside-5'-phosphate ester | Ajinomoto Co., Inc. (JP) | 1998-08-12 | — | — | EP | disclosed |
| EP-0832970-A1 | PROCESS FOR PRODUCING NUCLEOSIDE-5'-PHOSPHATE | Ajinomoto Co., Inc. (JP) | 1998-04-01 | — | — | EP | disclosed |